These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 21883400

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Serum levels of soluble vascular endothelial growth factor receptor-2 in patients with systemic sclerosis.
    Jinnin M, Makino T, Kajihara I, Honda N, Makino K, Ogata A, Ihn H.
    Br J Dermatol; 2010 Apr; 162(4):751-8. PubMed ID: 19886888
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The circulating cell-free microRNA profile in systemic sclerosis is distinct from both healthy controls and systemic lupus erythematosus.
    Steen SO, Iversen LV, Carlsen AL, Burton M, Nielsen CT, Jacobsen S, Heegaard NH.
    J Rheumatol; 2015 Feb; 42(2):214-21. PubMed ID: 25399392
    [Abstract] [Full Text] [Related]

  • 5. Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus.
    Wang H, Peng W, Ouyang X, Li W, Dai Y.
    Transl Res; 2012 Sep; 160(3):198-206. PubMed ID: 22683424
    [Abstract] [Full Text] [Related]

  • 6. Elevation of serum lymphotactin levels in patients with systemic sclerosis.
    Muroi E, Ogawa F, Shimizu K, Komura K, Hasegawa M, Fujimoto M, Sato S.
    J Rheumatol; 2008 May; 35(5):834-8. PubMed ID: 18322986
    [Abstract] [Full Text] [Related]

  • 7. Serum CCL23 levels are increased in patients with systemic sclerosis.
    Yanaba K, Yoshizaki A, Muroi E, Ogawa F, Asano Y, Kadono T, Sato S.
    Arch Dermatol Res; 2011 Jan; 303(1):29-34. PubMed ID: 20824279
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. miR-150 down-regulation contributes to the constitutive type I collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin β3.
    Honda N, Jinnin M, Kira-Etoh T, Makino K, Kajihara I, Makino T, Fukushima S, Inoue Y, Okamoto Y, Hasegawa M, Fujimoto M, Ihn H.
    Am J Pathol; 2013 Jan; 182(1):206-16. PubMed ID: 23159943
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Increased serum interleukin 23 in patients with systemic sclerosis.
    Komura K, Fujimoto M, Hasegawa M, Ogawa F, Hara T, Muroi E, Takehara K, Sato S.
    J Rheumatol; 2008 Jan; 35(1):120-5. PubMed ID: 18085738
    [Abstract] [Full Text] [Related]

  • 12. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
    York MR, Nagai T, Mangini AJ, Lemaire R, van Seventer JM, Lafyatis R.
    Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
    [Abstract] [Full Text] [Related]

  • 13. Increased serum levels of miR-1266 in patients with psoriasis vulgaris.
    Ichihara A, Jinnin M, Oyama R, Yamane K, Fujisawa A, Sakai K, Masuguchi S, Fukushima S, Maruo K, Ihn H.
    Eur J Dermatol; 2012 Mar; 22(1):68-71. PubMed ID: 22133505
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Increased cutaneous T-cell-attracting chemokine levels in sera from patients with systemic sclerosis.
    Hayakawa I, Hasegawa M, Matsushita T, Yanaba K, Kodera M, Komura K, Takehara K, Sato S.
    Rheumatology (Oxford); 2005 Jul; 44(7):873-8. PubMed ID: 15797972
    [Abstract] [Full Text] [Related]

  • 16. Serum and urinary free microRNA level in patients with systemic lupus erythematosus.
    Wang G, Tam LS, Li EK, Kwan BC, Chow KM, Luk CC, Li PK, Szeto CC.
    Lupus; 2011 Apr; 20(5):493-500. PubMed ID: 21372198
    [Abstract] [Full Text] [Related]

  • 17. Elevated serum APRIL levels in patients with systemic sclerosis: distinct profiles of systemic sclerosis categorized by APRIL and BAFF.
    Matsushita T, Fujimoto M, Hasegawa M, Tanaka C, Kumada S, Ogawa F, Takehara K, Sato S.
    J Rheumatol; 2007 Oct; 34(10):2056-62. PubMed ID: 17896803
    [Abstract] [Full Text] [Related]

  • 18. Altered diurnal rhythm of prolactin in systemic sclerosis.
    Hilty C, Brühlmann P, Sprott H, Gay RE, Michel BA, Gay S, Neidhart M.
    J Rheumatol; 2000 Sep; 27(9):2160-5. PubMed ID: 10990228
    [Abstract] [Full Text] [Related]

  • 19. Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis.
    Furuse S, Fujii H, Kaburagi Y, Fujimoto M, Hasegawa M, Takehara K, Sato S.
    J Rheumatol; 2003 Jul; 30(7):1524-8. PubMed ID: 12858452
    [Abstract] [Full Text] [Related]

  • 20. Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis.
    Kuwatsuka Y, Ogawa F, Iwata Y, Komura K, Muroi E, Hara T, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S.
    Autoimmunity; 2009 Feb; 42(2):120-5. PubMed ID: 19021012
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.